Treatment of pediatric relapsed and refractory acute myeloid leukemia
Background. Despite the modern therapy programs including hematopoietic stem cell transplantation, the treatment outcomes for children with acute myeloid leukemia (AML) remain unsatisfactory. The 5‑year overall survival rate is about 70 %. The 5‑year overall survival rate for patients with relapsed...
| Published in: | Онкогематология |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-05-01
|
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/815 |